Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies
The progression rates of Alzheimer’s disease (AD) are variable and dynamic, yet the mechanisms that contribute to heterogeneity in progression rates remain ill-understood. Particularly, the role of synergies i...